FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34181611000001104: Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2880121000001110 Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2880141000001117 Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Is a Drospirenone 3mg / Ethinylestradiol 30microgram tablets 63 tablet true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has AMP Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start